Same-day prescribing of daily oral pre-exposure prophylaxis for HIV prevention

Sarah E. Rowan, Rupa R. Patel, John A. Schneider, Dawn K. Smith

Research output: Contribution to journalReview articlepeer-review

13 Scopus citations

Abstract

Pre-exposure prophylaxis (PrEP) is highly effective in reducing HIV transmission but remains underutilised globally. Same-day PrEP prescribing and medication provision is an emerging implementation approach. The experiences of the three same-day PrEP programmes support the feasibility of the approach. Key elements of safe and effective same-day PrEP programmes include the ability to order laboratory tests at the time of the clinical visit and the ability to contact patients when laboratory results are available. Same-day PrEP has the potential to alleviate the attrition seen in usual care between initial evaluation and receipt of a PrEP prescription. A widespread application of same-day prescribing will be needed to assess its effect on PrEP usage.

Original languageEnglish
Pages (from-to)e114-e120
JournalThe Lancet HIV
Volume8
Issue number2
DOIs
StatePublished - Feb 2021

Fingerprint

Dive into the research topics of 'Same-day prescribing of daily oral pre-exposure prophylaxis for HIV prevention'. Together they form a unique fingerprint.

Cite this